| Name: | Atorvastatin Acetonide Methyl Ester Impurity |
| Catalogue No. | VL10037 |
| CAS No. | 1553049-81-6 |
| Molecular Formula | C37H41FN2O5 |
| Molecular Weight | 612.73 |
| Status | In-Stock |
| IUPAC Name | (4R,6R)-6-[2-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenyl amino) carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxane-4-acetic acid methyl ester |
| Synonyms | Atorvastatin Acetonide Methyl Ester |
| Description | Atorvastatin Acetonide Methyl Ester(CAS No: 1553049-81-6)or (4R,6R)-6-[2-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenyl amino) carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxane-4-acetic acid methyl ester, its acts as inhibits 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase By preventing the conversion of HMG-CoA to mevalonate. |
| References | McIver, Lindsey A., and Momin S. Siddique. “Atorvastatin.” Nih.gov, StatPearls Publishing, 5 Jan. 2019, www.ncbi.nlm.nih.gov/books/NBK430779/. Ramkumar, Satish, et al. “Statin Therapy: Review of Safety and Potential Side Effects.” Acta Cardiologica Sinica, vol. 32, no. 6, Taiwan Society of Cardiology, 2016, pp. 631–39, https://doi.org/10.6515/ACS20160611A. |
